OBJECTIVE: To assess the effectiveness of sodium nitroprusside (SNP)-"enhanced" cardiopulmonary resuscitation (SNPeCPR) on 24-hr survival rates compared to standard CPR in animals after cardiac arrest. SNPeCPR consists of large intravenous SNP bolus doses during CPR enhanced by active compression-decompression CPR, an inspiratory impedance threshold device (ITD), and abdominal binding (AB). The combination of active compression-decompression CPR+ITD+AB without SNP will be called "enhanced" or eCPR. DESIGN: Randomized, blinded, animal study. SETTING: Preclinical animal laboratory. SUBJECTS: Twenty-four female farm pigs (30 ± 1 kg). INTERVENTIONS: Isoflurane anesthetized and intubated pigs were randomized after 8 mins of untreated ventricular fibrillation to receive either standard CPR (n = 8), SNPeCPR (n = 8), or eCPR (n = 8) for 25 mins followed by defibrillation. MEASUREMENTS AND MAIN RESULTS: The primary end point was carotid blood flow during CPR and 24-hr survival with good neurologic function defined as an overall performance category score of ≤2 (1 = normal, 5 = brain dead or dead). Secondary end points included hemodynamics and end-tidal CO2. SNPeCPR significantly improved carotid blood flow and 24-hr survival rates with good neurologic function compared to standard CPR or eCPR (six of eight vs. zero of eight vs. one of eight, p < .05). The improved survival rates were associated with higher coronary perfusion pressure and ETco2 during CPR. CONCLUSION: In pigs, SNPeCPR significantly improved hemodynamics, resuscitation rates, and 24-hr survival rates with good neurologic function after cardiac arrest when compared with standard CPR or eCPR alone.
OBJECTIVE: To assess the effectiveness of sodium nitroprusside (SNP)-"enhanced" cardiopulmonary resuscitation (SNPeCPR) on 24-hr survival rates compared to standard CPR in animals after cardiac arrest. SNPeCPR consists of large intravenous SNP bolus doses during CPR enhanced by active compression-decompression CPR, an inspiratory impedance threshold device (ITD), and abdominal binding (AB). The combination of active compression-decompression CPR+ITD+AB without SNP will be called "enhanced" or eCPR. DESIGN: Randomized, blinded, animal study. SETTING: Preclinical animal laboratory. SUBJECTS: Twenty-four female farm pigs (30 ± 1 kg). INTERVENTIONS:Isoflurane anesthetized and intubated pigs were randomized after 8 mins of untreated ventricular fibrillation to receive either standard CPR (n = 8), SNPeCPR (n = 8), or eCPR (n = 8) for 25 mins followed by defibrillation. MEASUREMENTS AND MAIN RESULTS: The primary end point was carotid blood flow during CPR and 24-hr survival with good neurologic function defined as an overall performance category score of ≤2 (1 = normal, 5 = brain dead or dead). Secondary end points included hemodynamics and end-tidal CO2. SNPeCPR significantly improved carotid blood flow and 24-hr survival rates with good neurologic function compared to standard CPR or eCPR (six of eight vs. zero of eight vs. one of eight, p < .05). The improved survival rates were associated with higher coronary perfusion pressure and ETco2 during CPR. CONCLUSION: In pigs, SNPeCPR significantly improved hemodynamics, resuscitation rates, and 24-hr survival rates with good neurologic function after cardiac arrest when compared with standard CPR or eCPR alone.
Authors: Demetris Yannopoulos; Vinay M Nadkarni; Scott H McKnite; Anu Rao; Kurt Kruger; Anja Metzger; David G Benditt; Keith G Lurie Journal: Circulation Date: 2005-08-01 Impact factor: 29.690
Authors: Graham Nichol; Elizabeth Thomas; Clifton W Callaway; Jerris Hedges; Judy L Powell; Tom P Aufderheide; Tom Rea; Robert Lowe; Todd Brown; John Dreyer; Dan Davis; Ahamed Idris; Ian Stiell Journal: JAMA Date: 2008-09-24 Impact factor: 56.272
Authors: J J Shultz; P Coffeen; M Sweeney; B Detloff; C Kehler; E Pineda; P Yakshe; S W Adler; M Chang; K G Lurie Journal: Circulation Date: 1994-02 Impact factor: 29.690
Authors: Lauren Phillips; Alexander H Toledo; Fernando Lopez-Neblina; Roberto Anaya-Prado; Luis H Toledo-Pereyra Journal: J Invest Surg Date: 2009 Jan-Feb Impact factor: 2.533
Authors: Jason C Schultz; Nicolas Segal; Emily Caldwell; James Kolbeck; Scott McKnite; Nick Lebedoff; Menekhem Zviman; Tom P Aufderheide; Demetris Yannopoulos Journal: Crit Care Med Date: 2011-12 Impact factor: 7.598
Authors: Demetris Yannopoulos; Nicolas Segal; Scott McKnite; Tom P Aufderheide; Keith G Lurie Journal: Crit Care Med Date: 2012-05 Impact factor: 7.598
Authors: Guillaume Debaty; Anja Metzger; Jennifer Rees; Scott McKnite; Laura Puertas; Demetris Yannopoulos; Keith Lurie Journal: Crit Care Med Date: 2015-05 Impact factor: 7.598
Authors: Jason Schultz; Nicolas Segal; James Kolbeck; Emily Caldwell; Marit Thorsgard; Scott McKnite; Tom P Aufderheide; Keith G Lurie; Demetris Yannopoulos Journal: Resuscitation Date: 2011-12 Impact factor: 5.262
Authors: Jason Schultz; Nicolas Segal; James Kolbeck; Scott McKnite; Emily Caldwell; Demetris Yannopoulos Journal: Resuscitation Date: 2011-08-22 Impact factor: 5.262
Authors: Guillaume Debaty; Timothy R Matsuura; Jason A Bartos; Jennifer N Rees; Scott H McKnite; Michael Lick; François Boucher; Demetris Yannopoulos Journal: Crit Care Med Date: 2015-04 Impact factor: 7.598
Authors: Nicolas Segal; Timothy Matsuura; Emily Caldwell; Mohammad Sarraf; Scott McKnite; Menekhem Zviman; Tom P Aufderheide; Henry R Halperin; Keith G Lurie; Demetris Yannopoulos Journal: Resuscitation Date: 2012-04-18 Impact factor: 5.262
Authors: Demetris Yannopoulos; Nicolas Segal; Timothy Matsuura; Mohammad Sarraf; Marit Thorsgard; Emily Caldwell; Jennifer Rees; Scott McKnite; Karen Santacruz; Keith G Lurie Journal: Resuscitation Date: 2013-01-29 Impact factor: 5.262
Authors: Johanna C Moore; Bayert Salverda; Carolina Rojas-Salvador; Michael Lick; Guillaume Debaty; Keith G Lurie Journal: Resuscitation Date: 2020-10-04 Impact factor: 5.262